Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.12% |
| 2 | Technology | 11.12% |
| 3 | Financials | 10.62% |
| 4 | Consumer Discretionary | 8.46% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Procter & Gamble
PG
$343B
| $166M | 0.25% |
1,509,909
+588,167
| +64% | +$62.7M |
|
52
Entergy
ETR
$54.1B
| $165M | 0.25% |
3,200,662
+436,726
| +16% | +$21.3M |
|
53
Bio-Rad Laboratories Class A
BIO
$8.42B
| $164M | 0.25% |
525,924
+105,050
| +25% | +$31.5M |
|
|
ETFC
54
DELISTED
E*Trade Financial Corporation
ETFC
| $161M | 0.24% |
3,601,961
+294,221
| +9% | +$14.1M |
|
55
Meta Platforms (Facebook)
META
$1.51T
| $160M | 0.24% |
827,265
-201,696
| -20% | -$36.9M |
|
|
NBL
56
DELISTED
Noble Energy, Inc.
NBL
| $160M | 0.24% |
7,124,013
+5,351,433
| +302% | +$127M |
|
57
S&P Global
SPGI
$126B
| $159M | 0.24% |
696,625
+159,996
| +30% | +$34.9M |
|
58
Honeywell
HON
$77.1B
| $156M | 0.23% |
947,714
-801,576
| -46% | -$128M |
|
59
PUT
Netflix
NFLX
$292B
| $153M | 0.23% |
4,155,000
+1,485,000
| +56% | +$53.6M |
|
60
Zoetis
ZTS
$31.6B
| $153M | 0.23% |
1,344,530
-128,629
| -9% | -$13.5M |
|
61
PUT
iShares Russell 2000 ETF
IWM
$80.9B
| $152M | 0.23% |
978,800
-476,500
| -33% | -$73.5M |
|
62
Gilead Sciences
GILD
$161B
| $149M | 0.22% |
2,208,668
-1,745,720
| -44% | -$115M |
|
63
Regeneron Pharmaceuticals
REGN
$68.8B
| $148M | 0.22% |
473,318
+439,550
| +1,302% | +$146M |
|
64
IQVIA
IQV
$34.7B
| $148M | 0.22% |
916,872
+399,364
| +77% | +$56M |
|
65
CALL
Alphabet (Google) Class A
GOOGL
$3.91T
| $147M | 0.22% |
2,708,000
+1,108,000
| +69% | +$64.1M |
|
66
Kimberly-Clark
KMB
$36.4B
| $145M | 0.22% |
1,088,825
+449,729
| +70% | +$58M |
|
67
D.R. Horton
DHI
$41B
| $145M | 0.22% |
3,358,499
+1,321,944
| +65% | +$58.5M |
|
68
Humana
HUM
$46.7B
| $144M | 0.22% |
543,520
+384,300
| +241% | +$97.5M |
|
69
UnitedHealth
UNH
$382B
| $144M | 0.22% |
590,921
+230,140
| +64% | +$55.4M |
|
|
HRC
70
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $144M | 0.22% |
1,372,490
+299,144
| +28% | +$30.3M |
|
71
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $143M | 0.21% |
2,671,400
+976,800
| +58% | +$52.2M |
|
72
Goldman Sachs
GS
$313B
| $142M | 0.21% |
693,186
+560,071
| +421% | +$111M |
|
|
ARRY
73
DELISTED
Array Biopharma Inc
ARRY
| $140M | 0.21% |
3,021,920
+1,500,142
| +99% | +$42.1M |
|
74
PUT
PayPal
PYPL
$49.5B
| $136M | 0.2% |
1,189,800
+451,300
| +61% | +$50M |
|
75
Dentsply Sirona
XRAY
$2.59B
| $136M | 0.2% |
2,323,390
+1,357,763
| +141% | +$73M |
|
Similar funds
Millennium Management's Q2 2019 Portfolio in Review
As of Q2 2019, Millennium Management held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Millennium Management's Q2 2019 filing shows 865 new, 1,488 increased, 1,571 reduced and 810 closed positions. Its largest new stake was Moody's: 638,271 shares worth $125M. The largest sale was Walt Disney, an estimated $568M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
- Millennium Management's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Millennium Management added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Millennium Management's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Millennium Management fully exited Sysco in Q2 2019, selling an estimated $208M.
- Millennium Management's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Millennium Management opened 865 new positions and closed 810 in Q2 2019.
- Millennium Management's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.